A clinical study exploring a non-steroidal, non-opioidal medication for patients suffering with sciatica or leg pain from a herniated lumbar disc is enrolling patients in the U.S.
Three things to know:
1. The study will enroll 320 people aged 30 to 70 years old who have been diagnosed with leg pain from a herniated lumbar disc.
2. A Phase 3 study in Japan demonstrated that an injection of the drug into the nucleus pulposus reduced nerve root by decreasing pressure and volume of herniation, resulting in less pain.
3. SI-6603, the study drug, has yet to be approved for use in the U.S. by the FDA.